Children and young people with disabilities and severe complex needs: integrated health and social care support
Proposed [GID-QS10146] Expected publication date: TBC
Search results
2384 results
-
-
Safeguarding adults in care homes
Proposed [GID-QS10147] Expected publication date: TBC
-
Social work interventions for adults with complex needs (including learning disabilities) and mental health needs
Proposed [GID-QS10148] Expected publication date: TBC
-
Supporting independent living and preventing isolation in adults of working age with social care needs
Proposed [GID-QS10149] Expected publication date: TBC
-
Brain tumours (primary) and brain metastases in adults
In development [GID-QS10092] Expected publication date: TBC
-
Colorectal cancer (QS update)
In development [GID-QS10141] Expected publication date: TBC
-
Infant, children and young people's experience of health care
Proposed [GID-QS10102] Expected publication date: TBC
-
Gambling
Proposed [GID-QS10099] Expected publication date: TBC
-
Vulnerable populations: strategies for tackling inequalities
Proposed [GID-QS10124] Expected publication date: TBC
-
Gout
Proposed [GID-QS10100] Expected publication date: TBC
-
Pernicious anaemia
Proposed [GID-QS10130] Expected publication date: TBC
-
Tinnitus
Proposed [GID-QS10091] Expected publication date: TBC
-
Heart valve disease in adults
Proposed [GID-QS10101] Expected publication date: TBC
-
Diverticular disease
Proposed [GID-QS10086] Expected publication date: TBC
-
Acne
Proposed [GID-QS10036] Expected publication date: TBC
-
Pain management (young people and adults)
Proposed [GID-QS10093] Expected publication date: TBC
-
Adrenal dysfunction
Proposed [GID-QS10038] Expected publication date: TBC
-
Pancreatitis (including acute pancreatitis)
Proposed [GID-QS10085] Expected publication date: TBC
-
Thyroid disease
Proposed [GID-QS10088] Expected publication date: TBC
-
Primary hyperparathyroidism
Proposed [GID-QS10089] Expected publication date: TBC
-
Sleep disordered breathing
Proposed [GID-QS10096] Expected publication date: TBC
-
Managing symptoms with an uncertain cause
Proposed [GID-QS10103] Expected publication date: TBC
-
Safe prescribing and withdrawal management of prescribed drugs associated with dependence and withdrawal
Proposed [GID-QS10106] Expected publication date: TBC
-
Readmission to ICU within 48hrs
Proposed [GID-QS10105] Expected publication date: TBC
-
Secondary care management of malignant hypertension
Proposed [GID-QS10107] Expected publication date: TBC
-
Prevention of dementia
Proposed [GID-QS10109] Expected publication date: TBC
-
Indoor air quality at home
In development [GID-QS10113] Expected publication date: TBC
-
Joint replacement (primary): hip, knee and shoulder
In development [GID-QS10090] Expected publication date: TBC
-
Neonatal parenteral nutrition
In development [GID-QS10087] Expected publication date: TBC
-
Perioperative care
In development [GID-QS10094] Expected publication date: TBC
-
School-based interventions: physical and mental health and wellbeing promotion
In development [GID-QS10070] Expected publication date: TBC
-
Pelvic floor dysfunction
Proposed [GID-QS10129] Expected publication date: TBC
-
Shared decision-making: practical guidance for health and social care professionals
Proposed [GID-QS10097] Expected publication date: TBC
-
End of life care (QS update)
In development [GID-QS10140] Expected publication date: TBC
-
Fetal alcohol spectrum disorder
In development [GID-QS10139] Expected publication date: TBC
-
Venous thromboembolic diseases (QS update)
In development [GID-QS10142] Expected publication date: TBC
-
Supporting adult carers
In development [GID-QS10128] Expected publication date: 19 March 2021
-
Workplace health: long-term sickness absence and capability to work
In development [GID-QS10114] Expected publication date: TBC
-
Renin-angiotensin system drugs: dual therapy (KTT2)
The key therapeutic topic renin-angiotensin system drugs: dual therapy has been retired from the 2017 update of medicines optimisation: key therapeutic topics. The version published in 2016 is available here for information but it has not been updated since February 2016. Like all the other key therapeutic topics it is not formal NICE guidance .
-
Minocycline (KTT11)
The key therapeutic topic minocycline has been retired from the 2016 update of medicines optimisation: key therapeutic topics. The version published in 2015 is available here for information but it has not been updated since January 2015. Like all the other key therapeutic topics it is not formal NICE guidance .
-
Laxatives (KTT1)
The key therapeutic topic laxatives has been retired from the 2016 update of medicines optimisation: key therapeutic topics. The version published in 2015 is available here for information but it has not been updated since January 2015. Like all the other key therapeutic topics it is not formal NICE guidance .
-
First-choice antidepressant use in adults with depression or generalised anxiety disorder (KTT8)
The key therapeutic topic first-choice antidepressant use in adults with depression or generalised anxiety disorder has been retired from the 2017 update of medicines optimisation: key therapeutic topics. The version published in 2016 is available here for information but it has not been updated since February 2016. Like all the other key therapeutic topics it is not formal NICE guidance .
-
Antimicrobial stewardship: prescribing antibiotics (KTT9)
This document summarises the evidence base on antimicrobial stewardship: prescribing antibiotics . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .
-
Antipsychotics in people living with dementia (KTT7)
This document summarises the evidence base on antipsychotics in people living with dementia . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .
-
Hypnotics (KTT6)
This document summarises the evidence base on hypnotics . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .
-
Asthma: medicines safety priorities (KTT5)
This document summarises the evidence base on asthma: medicines safety priorities . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .
-
Lipid-modifying drugs (KTT3)
This key therapeutic topic has been reincluded in the September 2019 update of medicines optimisation: key therapeutic topics. This document summarises the evidence base on lipid-modifying drugs. It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .
-
Suicide prevention: optimising medicines and reducing access to medicines as a means of suicide (KTT24)
This document summarises the evidence base on suicide prevention: optimising medicines and reducing access to medicines as a means of suicide . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .
-
Shared decision making (KTT23)
This document summarises the evidence base on shared decision making . It is a key therapeutic topic that has been identified to support Medicines Optimisation. It is not formal NICE guidance .
-
Chemotherapy dose standardisation (KTT22)
This document summarises the evidence base on chemotherapy dose standardisation . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .